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The field of exposure science began with qualitative observations and 
quantitative measurements of air contaminants to aid our under­
standing of exposure–disease relationships. In fact, some of the earli­
est writings that describe the essence of exposure science are found 
in Bernardino Ramazzini’s 1700 treatise on occupational diseases 
(Franco 1999). In the 1920s, exposure scientists collaborated with 
epidemiolo  gists to investigate workplace exposures as sources of occu­
pational diseases (Rappaport 2011). Between the 1950s and 1970, 
investigations expanded to include exposures to pollutants in ambient 
and indoor air and water (Rappaport 2011). Following establishment 
of U.S. governmental agencies in the 1970s to regulate exposures in 
the workplace (Occupational Safety and Health Administration) and 
the ambient environment [U.S. Environmental Protection Agency 
(EPA)], the paths of exposure scientists diverged into those investigat­
ing sources of pollutants in occupational settings and those investigat­
ing ambient sources of pollutants (Rappaport 2011). By the 1990s 
the two groups had essentially parted ways, and the term “exposure 
science” was associated with community and personal exposures to 
ambient pollutants (Lioy 2010; Ott 1990, 1995). Investigations of 
total personal exposure initially employed external measure  ments of 
chemicals that can enter the body by inhalation, ingestion, and dermal 
contact (1970s), and internal markers of exposure were added in the 
1980s and 1990s (Centers for Disease Control and Prevention 2009; 
Hoffmann et al. 2000; Sexton et al. 1995; Wallace et al. 1985). In the 
21st century, exposure science has increasingly embraced deterministic 
models to predict levels of diverse exposures based on categori  cal data 
(Cohen Hubal et al. 2010; Georgopoulos and Lioy 2006; Lioy 2010) 
and on meas  ured levels of pollutants in biological fluids and tissues 
(Georgopoulos et al. 2009). 
In parallel with the above activities, during the 1980s and 1990s, 
molecular epidemiologists explored links between genetic and environ­
mental factors and the resulting biochemical or biological indicators of 
possible ill health (biomarkers) measured in individual subjects (Bonassi 
and Au 2002). When completion of the human genome project in 2000 
made it feasible to measure thousands of polymorphic genes in each sub­
ject, epidemiology increasingly focused on the genetic determinants of 
diseases (Hindorff et al. 2009). However, as results of these genome­wide 
association studies (GWAS) failed to explain most variability in human 
diseases (Manolio et al. 2009), interest in environmental factors reemerged. 
But there was no environ  mental analog of GWAS; that is, we had no 
way of characterizing the totality of a person’s environmental exposures. 
This prompted Christopher Wild to publish a commentary that defined 
the “exposome” as the environmental complement to the genome (Wild 
2005). Recognizing that humans are exposed to health­impairing agents 
from both pollution and non  pollution sources and that these sources 
change during a lifetime, Wild indicated that “… the exposome encom­
passes life­course environmental exposures (including lifestyle factors) from 
the pre  natal period onwards.” This is a powerful idea because it considers 
a person’s lifetime history of all exposures experienced from both exter­
nal sources (e.g. pollution, radiation, and diet) and internal sources (e.g. 
inflammation, infection, and the micro  biome) (Rappaport and Smith 
2010). Thus, one can imagine a future in which individuals’ exposomes 
are contrasted between diseased and healthy populations for molecular 
epidemiology, or over different life stages as part of personalized medicine 
(Nicholson 2006). In either case, the goal would be to discover causes of ill 
health and to generate 
hypotheses regarding 
identification and elim­
ination or reduction of 
harmful exposures. 
If the exposome concept is to be useful to exposure science, methods   
will be needed to characterize individual exposomes and to investi­
gate sources of exposome variability. Because exposures arise from 
diverse sources, Rappaport defined two generic approaches for charac­
terizing exposomes (Rappaport 2011; Rappaport and Smith 2010). 
A “bottom­up” approach would focus on each category of external 
exposure—including air, water, diet, radiation, lifestyle, etc.—to 
quantify contaminant levels that would be summed over all cate­
gories to estimate individual exposomes. This approach is appealing 
to some exposure scientists because it focuses on the same external 
media that have long been investigated and leads logically to interven­
tions for eliminating or reducing exposures. However, this bottom­up 
approach would require tremendous effort to evaluate the myriad of 
largely unknown analytes in various external media and would also 
miss important endogenous exposures. The alternative “top­down” 
approach would adopt untargeted omic methods to measure features 
of exposures in biological fluids, and thus finds appeal with exposure 
scientists who have used biomonitoring for assessing exposure levels, 
albeit on a chemical­by­chemical basis. This approach is more effi­
cient because both exogenous and endogenous exposures would be 
represented by a single specimen of blood, for example, and would 
encourage contrasts of omic profiles between diseased and healthy 
populations in much the same manner as GWAS (Patel et al. 2010). 
Omic profiles would generate hypotheses to a) indentify particular 
exposures, b) develop specific biomarkers for high­throughput screens, 
and c) determine sources of external and internal exposure. Recent 
untargeted metabolomic studies have applied this top­down approach 
to identify hitherto unknown exposures associated with cardio  vascular 
disease (Holmes et al. 2008; Wang et al. 2011). 
When examined objectively, there is scientific value in both the 
bottom­up and top­down approaches for characterizing individual expo­
somes. The top­down approach offers appeal for discovering unknown 
causes of human disease (Rappaport 2011; Rappaport and Smith 2010), 
whereas the bottom­up approach encourages more comprehensive analy­
ses of external exposures and methods for inter  vention and prevention 
(Lioy 2010). Indeed, we envision long­term strategies that embrace ele­
ments of both approaches for improving public health. Unfortunately, 
the differentiation between external (air, water, soil/dust, etc.) and internal 
(biological fluids) media has led to an apparent dis  connect or competi­
tion between exposure scientists who focus on external monitoring and 
modeling and those who favor biomonitoring and omic methods. Indeed, 
we are encountering a view that can be summarized as “exposure science 
versus the exposome.” This is counter  productive because it potentially 
deprives exposure science of avenues for vastly diversifying its pool of 
rele  vant exposures and for strengthening the source­to­dose framework 
needed by the environmental health sciences. Rather than adopting 
defensive postures, we encourage exposure scientists to exploit the rela­
tive strengths of both monitoring approaches for assessing human expo­
sures. Toward this end, the National Academy of Sciences will convene 
a workshop in December 2011 to better integrate the top­down and 
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bottom­up approaches for characterizing individual exposomes (Emerging 
Technologies for Measuring Individual Exposomes, 8–9 December 
2011, Washington, DC; information is available at http://dels.nas.edu/
envirohealth). 
Other recent developments offer opportunities for exposure scien­
tists to characterize individual exposomes. For example, the National 
Children’s Study (Landrigan et al. 2006) offers an evolving platform 
with which to link the top­down and bottom­up approaches. Because 
individual data and bio  specimens will be collected during the first 
21 years of life, this study will provide resources that can be used 
to evaluate the variability of exposome features during critical life 
stages. Moreover, the extensive questionnaire data, home samples, 
extant environ  mental data, and dietary histories of participants suggest 
avenues for modeling connections between the internal and external 
environments. Such prospective cohort studies will allow us to collect 
more and better exposure data with which to identify unknown health 
hazards and to develop appropriate preventive measures and regula­
tions for recognized hazards. The exposome concept can play a key role 
in both endeavors.
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